ARDANE THERAPEUTICS

Basic Information

1 Davol Square
Suite 200
PROVIDENCE, RI, 02903-

Company Profile

n/a

Additional Details

Field Value
DUNS: 831336883
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Treatment of stroke using a novel PDZ binding peptidomimetic drug.

    Amount: $352,596.00

    DESCRIPTION (provided by applicant): Abstract Stroke is the third leading pathological cause of death, behind heart and cancer (NCHS mortality data.). We are developing a new drug, CN 2097, that h ...

    SBIR Phase I 2011 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government